KIMBERLY MANHARD - EVP, Drug Development at HERON THERAPEUTICS, INC. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Drug Development
Issuer Symbol
HRTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by KIMBERLY MANHARD since 13 Feb 2025

Holdings reported by KIMBERLY MANHARD for HERON THERAPEUTICS, INC. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (Right to Buy) 165,961 $295,411 $1.78 25 Jul 2022 Direct Common Stock
Common Stock 28,330 $60,910 $2.15 13 Apr 2023 Direct
Restricted Stock Units 27,936 $60,062 $2.15 13 Apr 2023 Direct Common Stock
Performance Stock Units 149,365 18 Jan 2023 Direct Common Stock

Transactions reported by KIMBERLY MANHARD for HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.